We previously observed that Mcl-1 is increased in the imatinib-resistant CML cell line (MYL-R) characterized by overexpression and activity of the Src family kinase, Lyn [14,29,35,36]. The gene discussed is MCL1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.